Don't want ads? Subscribe or login now.

Ex-Merck VP Says Investors 'Overstate' Omnicare Impact

By Stephanie Russell-Kraft · March 31, 2015, 4:50 PM EDT

Attorneys for a former Merck & Co. Inc. vice president accused of lying about study results on Vioxx's heart attack link told a New Jersey federal court Tuesday that, contrary to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Letter

Case Information

Case Title

MERCK & CO., INC., SECURITIES, DERIVATIVE & "ERISA" LITIGATION

Case Number

2:05-cv-01151

Court

New Jersey

Nature of Suit

Labor: Other

Date Filed

February 28, 2005

Recent Articles By Stephanie

July 16, 2015
Dodd-Frank Act At 5: The Rules That Are Still Lagging
June 09, 2015
Agencies Issue Diversity Hiring Standards For Banks, Brokers
June 04, 2015
SEC Issues Pay-Ratio Study After Scathing Warren Letter
May 01, 2015
CFTC Whistleblower Head Forecasts Big Things To Come
April 29, 2015
SEC Uses Firm's Retaliation To Market Tipster Program
April 28, 2015
SEC Awards $600K To Tipster In Paradigm Retaliation Case
April 22, 2015
SEC Grants $1.5M Whistleblower Award To Compliance Officer
April 07, 2015
5 Tricky Questions Posed By SEC Rule On Employee Pacts
April 01, 2015
SEC Declares Open Season On Employee Agreements
April 01, 2015
SEC Brings 1st Whistleblower Action Over Confidentiality Pact